Animal Disease Model - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510244130

Publication Date:

October 21, 2024

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Animal disease models refer to animals with simulated performance of human diseases established in various medical scientific researches.
The global market for Animal Disease Model was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 313%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Animal Disease Model, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Animal Disease Model by region & country, by Type, and by Application.
The Animal Disease Model market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Disease Model.
麻豆原创 Segmentation
By Company
Charles River
Jackson Laboratory
Taconic Biosciences
Envigo
Crown Biosciences
GemPharmatech
Beijing Biocytogen
Shanghai Model Organisms Center
Pharmaron
Hanheng Biotechnology
Cyagen Biosciences
Segment by Type:
Tumor Disease Model
Metabolic Disease Model
Immune and Non-Immune Inflammatory Disease Models
Cns Disease Models
Rare Disease Model
Segment by Application
Experimental Physiology
Experimental Pathology
Experimental Therapeutics (Including New Drug Screening)
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Animal Disease Model manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Animal Disease Model in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Animal Disease Model in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Animal Disease Model Product Introduction
1.2 Global Animal Disease Model 麻豆原创 Size Forecast
1.3 Animal Disease Model 麻豆原创 Trends & Drivers
1.3.1 Animal Disease Model Industry Trends
1.3.2 Animal Disease Model 麻豆原创 Drivers & Opportunity
1.3.3 Animal Disease Model 麻豆原创 Challenges
1.3.4 Animal Disease Model 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal Disease Model Players Revenue Ranking (2023)
2.2 Global Animal Disease Model Revenue by Company (2019-2024)
2.3 Key Companies Animal Disease Model Manufacturing Base Distribution and Headquarters
2.4 Key Companies Animal Disease Model Product Offered
2.5 Key Companies Time to Begin Mass Production of Animal Disease Model
2.6 Animal Disease Model 麻豆原创 Competitive Analysis
2.6.1 Animal Disease Model 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Animal Disease Model Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Disease Model as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tumor Disease Model
3.1.2 Metabolic Disease Model
3.1.3 Immune and Non-Immune Inflammatory Disease Models
3.1.4 Cns Disease Models
3.1.5 Rare Disease Model
3.2 Global Animal Disease Model Sales Value by Type
3.2.1 Global Animal Disease Model Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Animal Disease Model Sales Value, by Type (2019-2030)
3.2.3 Global Animal Disease Model Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Experimental Physiology
4.1.2 Experimental Pathology
4.1.3 Experimental Therapeutics (Including New Drug Screening)
4.2 Global Animal Disease Model Sales Value by Application
4.2.1 Global Animal Disease Model Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Animal Disease Model Sales Value, by Application (2019-2030)
4.2.3 Global Animal Disease Model Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Animal Disease Model Sales Value by Region
5.1.1 Global Animal Disease Model Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Animal Disease Model Sales Value by Region (2019-2024)
5.1.3 Global Animal Disease Model Sales Value by Region (2025-2030)
5.1.4 Global Animal Disease Model Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Animal Disease Model Sales Value, 2019-2030
5.2.2 North America Animal Disease Model Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Animal Disease Model Sales Value, 2019-2030
5.3.2 Europe Animal Disease Model Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Animal Disease Model Sales Value, 2019-2030
5.4.2 Asia Pacific Animal Disease Model Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Animal Disease Model Sales Value, 2019-2030
5.5.2 South America Animal Disease Model Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Animal Disease Model Sales Value, 2019-2030
5.6.2 Middle East & Africa Animal Disease Model Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal Disease Model Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Animal Disease Model Sales Value
6.3 United States
6.3.1 United States Animal Disease Model Sales Value, 2019-2030
6.3.2 United States Animal Disease Model Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Animal Disease Model Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Animal Disease Model Sales Value, 2019-2030
6.4.2 Europe Animal Disease Model Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Animal Disease Model Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Animal Disease Model Sales Value, 2019-2030
6.5.2 China Animal Disease Model Sales Value by Type (%), 2023 VS 2030
6.5.3 China Animal Disease Model Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Animal Disease Model Sales Value, 2019-2030
6.6.2 Japan Animal Disease Model Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Animal Disease Model Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Animal Disease Model Sales Value, 2019-2030
6.7.2 South Korea Animal Disease Model Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Animal Disease Model Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Animal Disease Model Sales Value, 2019-2030
6.8.2 Southeast Asia Animal Disease Model Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Animal Disease Model Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Animal Disease Model Sales Value, 2019-2030
6.9.2 India Animal Disease Model Sales Value by Type (%), 2023 VS 2030
6.9.3 India Animal Disease Model Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Charles River
7.1.1 Charles River Profile
7.1.2 Charles River Main Business
7.1.3 Charles River Animal Disease Model Products, Services and Solutions
7.1.4 Charles River Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.1.5 Charles River Recent Developments
7.2 Jackson Laboratory
7.2.1 Jackson Laboratory Profile
7.2.2 Jackson Laboratory Main Business
7.2.3 Jackson Laboratory Animal Disease Model Products, Services and Solutions
7.2.4 Jackson Laboratory Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.2.5 Jackson Laboratory Recent Developments
7.3 Taconic Biosciences
7.3.1 Taconic Biosciences Profile
7.3.2 Taconic Biosciences Main Business
7.3.3 Taconic Biosciences Animal Disease Model Products, Services and Solutions
7.3.4 Taconic Biosciences Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.3.5 Envigo Recent Developments
7.4 Envigo
7.4.1 Envigo Profile
7.4.2 Envigo Main Business
7.4.3 Envigo Animal Disease Model Products, Services and Solutions
7.4.4 Envigo Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.4.5 Envigo Recent Developments
7.5 Crown Biosciences
7.5.1 Crown Biosciences Profile
7.5.2 Crown Biosciences Main Business
7.5.3 Crown Biosciences Animal Disease Model Products, Services and Solutions
7.5.4 Crown Biosciences Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.5.5 Crown Biosciences Recent Developments
7.6 GemPharmatech
7.6.1 GemPharmatech Profile
7.6.2 GemPharmatech Main Business
7.6.3 GemPharmatech Animal Disease Model Products, Services and Solutions
7.6.4 GemPharmatech Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.6.5 GemPharmatech Recent Developments
7.7 Beijing Biocytogen
7.7.1 Beijing Biocytogen Profile
7.7.2 Beijing Biocytogen Main Business
7.7.3 Beijing Biocytogen Animal Disease Model Products, Services and Solutions
7.7.4 Beijing Biocytogen Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.7.5 Beijing Biocytogen Recent Developments
7.8 Shanghai Model Organisms Center
7.8.1 Shanghai Model Organisms Center Profile
7.8.2 Shanghai Model Organisms Center Main Business
7.8.3 Shanghai Model Organisms Center Animal Disease Model Products, Services and Solutions
7.8.4 Shanghai Model Organisms Center Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.8.5 Shanghai Model Organisms Center Recent Developments
7.9 Pharmaron
7.9.1 Pharmaron Profile
7.9.2 Pharmaron Main Business
7.9.3 Pharmaron Animal Disease Model Products, Services and Solutions
7.9.4 Pharmaron Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.9.5 Pharmaron Recent Developments
7.10 Hanheng Biotechnology
7.10.1 Hanheng Biotechnology Profile
7.10.2 Hanheng Biotechnology Main Business
7.10.3 Hanheng Biotechnology Animal Disease Model Products, Services and Solutions
7.10.4 Hanheng Biotechnology Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.10.5 Hanheng Biotechnology Recent Developments
7.11 Cyagen Biosciences
7.11.1 Cyagen Biosciences Profile
7.11.2 Cyagen Biosciences Main Business
7.11.3 Cyagen Biosciences Animal Disease Model Products, Services and Solutions
7.11.4 Cyagen Biosciences Animal Disease Model Revenue (US$ Million) & (2019-2024)
7.11.5 Cyagen Biosciences Recent Developments
8 Industry Chain Analysis
8.1 Animal Disease Model Industrial Chain
8.2 Animal Disease Model Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal Disease Model Sales Model
8.5.2 Sales Channel
8.5.3 Animal Disease Model Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Charles River
Jackson Laboratory
Taconic Biosciences
Envigo
Crown Biosciences
GemPharmatech
Beijing Biocytogen
Shanghai Model Organisms Center
Pharmaron
Hanheng Biotechnology
Cyagen Biosciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.